According to TechSci Research report, “Europe Pharmacovigilance Market By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By End-User (Hospitals, Research Organizations, Industries), By Country, Forecast & Opportunities, 2028”, the Europe pharmacovigilance market is expected to undergo significant growth during the forecast period owing to the presence of strict regulatory framework for drug testing and approval in the region. Rising number of chronic disorders have led to increasing demand and consumption of pharmaceutical drugs. With increase in the manufacture of suitable drugs, the pharmacovigilance market is witnessing massive growth in the region. Further, mandatory drug safety monitoring by government is creating huge growth opportunities for pharmacovigilance service providers. Additionally, the pharmacovigilance market is gaining support for its growth with increasing number of pharmaceutical companies and harmonization practices. Moreover, spike in cases of Adverse Drug Reaction (ADR) is a major concern in Europe, which is expected to contribute to the growth of pharmacovigilance market during the forecast period. The fast pace of life and changing lifestyle pattern have led to lack of physical activities and poor diets, which results in increase in amount of drug consumption by an average individual. With growing consumption of pharmaceutical drugs, the pharmacovigilance market is expected to undergo massive growth until 2028. Also, patent expiration of branded drugs and increasing number of new drug developments are other key factors supporting the growth of Europe pharmacovigilance market
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “Europe Pharmacovigilance Market”
https://www.techsciresearch.com/report/europe-pharmacovigilance-market/4843.html
Growing incidences and prevalence of chronic diseases such as diabetes, hypertension, cardiovascular diseases, asthma, cancer, among others are likely to strengthen the growth of the market. According to the World Health Organisation (WHO), there are around 60 million people with diabetes in the Europe, out of which 10.3% are men and 9.6% are women aged 25 years and over. Moreover, rising elderly population is also a supporting factor as they are highly susceptible to these diseases. The rising number of cases of chronic diseases in the region is surging the demand for drugs, thereby, fuelling the growth of the market. In 2021, over one fifth (20.8 %) of the Europe population was aged 65 and above.
The Europe pharmacovigilance market is segmented based on clinical trial phase, method, service provider, end-user and region. Based on service provider, the market is categorized into in-house and contract outsourcing. Among these, the contract outsourcing service provider segment currently dominates the European market and is expected to hold its position during the forecast period as well. The reason behind this is that it eliminates the risk of business overhead costs and thus, is increasingly being adopted by healthcare companies. Contract outsourcing offers services including process design Standard Operating Procedure (SOP), pharmacovigilance audits, and others. Based on end-user, Europe pharmacovigilance market is categorized into hospitals, research organizations and industries. Among them, the research organizations segment is expected to undergo fastest growth in Europe owing to the increasing research and development activities being conducted by them for the development of novel drugs and medical devices.
Major players operating in the Europe pharmacovigilance market include Accenture PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb SARL, Clinquest Group B.V., F Hoffmann-La Roche AG, Foresight Group International AG, ICON PLC, GlaxoSmithKline PLC, Novartis AG and Capgemini SE. The companies are investing on R&D activities to offer more advanced services. Some leading players are also undertaking growth strategies such as collaborations, partnerships and alliance to increase their market reach in the region.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4843
Customers can also request for 10% free customization on this report.
“Europe has one of the best healthcare facilities in the world and has presence of some leading pharmaceutical giants. It continuous to engage in the manufacture of novel drugs, which is creating huge growth opportunities for pharmacovigilance service provider companies. The recent outbreak of COVID-19 has further led to rapid growth of the market as continuous test trials are being conducted for the development of the vaccine. As various healthcare companies in countries such as Italy and UK are coming together for the development of vaccines against coronavirus, the pharmacovigilance is set to witness massive growth in the region” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Europe Pharmacovigilance Market By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By End-User (Hospitals, Research Organizations, Industries), By Country, Forecast & Opportunities, 2028” has evaluated the future growth potential of Europe pharmacovigilance market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in Europe pharmacovigilance market.
Report Scope:
In this report, Europe pharmacovigilance market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Europe Pharmacovigilance Market, By Service Provider:
- In-house
- Contract Outsourcing
- Europe Pharmacovigilance Market, By Product Life Cycle:
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Europe Pharmacovigilance Market, By Type:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Europe Pharmacovigilance Market, By Process Flow:
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Europe Pharmacovigilance Market, By Therapeutic Area:
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Europe Pharmacovigilance Market, By End-Use:
- Pharmaceuticals & Biotechnology Companies
- Medical Device Manufacturers
- Others
- Europe Pharmacovigilance Market, By Country:
-
- France
- Germany
- United Kingdom
- Italy
- Spain
- Belgium
- Netherlands
- Sweden
- Poland
- Greece
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4843
Related Reports:
Global Thalassemia Diagnostics Market
Global Lupus Therapeutics Market
Global Virology Specimen Collection Market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com